Long-term tolerability of inhaled human insulin (Exubera®) in patients with poorly controlled type 2 diabetes (vol 61, pg 1614, 2007)

被引：0
|
作者：
Barnett, A. H.
Lange, P.
Dreyer, M.
Serdarevic-Pehar, M.
机构：
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2008年 / 62卷 / 01期
关键词：
D O I：
10.1111/j.1742-1241.2007.01664.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：171 / 171
页数：1
相关论文
共 50 条
  • [41] Safety and Efficacy of Inhaled Human Insulin (Exubera) During Discontinuation and Readministration of Therapy in Adults with Type 2 Diabetes: A 3-Year Randomized Controlled Trial
    Rosenstock, Julio
    Cefalu, William T.
    Hollander, Priscilla A.
    Klioze, Sol S.
    Reis, Joann
    Duggan, William T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (11) : 697 - 705
  • [42] Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes
    Goldfine, A. B.
    Fonseca, V. A.
    Jones, M. R.
    Wang, A. C.
    Ford, D. M.
    Truitt, K. E.
    HORMONE AND METABOLIC RESEARCH, 2010, 42 (01) : 23 - 30
  • [43] Long-term use of inhaled corticosteroids and the risk of type 2 diabetes in COPD
    Saeed, Mohamad Isam
    Eklof, Josefin
    Achir, Imane
    Sivapalan, Pradeesh
    Meteran, Howraman
    Lokke, Anders
    Sorensen, Tor-Biering
    Knop, Filip Krag
    Jensen, Jens-Ulrik Staehr
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [44] Within-subject variability of inhaled insulin (Exubera®) versus subcutaneous regular insulin in elderly obese patients with type 2 diabetes Mellitus
    Henry, R
    Mudaliar, S
    Fryburg, D
    Becker, R
    Willavize, S
    Fisher, J
    Fountaine, R
    Sha, S
    DIABETES, 2003, 52 : A105 - A105
  • [45] An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea - Response to Barnett et al.
    Mikhail, Nasser
    Cope, Dennis
    DIABETES CARE, 2006, 29 (10) : 2332 - 2333
  • [46] Individualized Meal Replacement Therapy Improves Clinically Relevant Long-Term Glycemic Control in Poorly Controlled Type 2 Diabetes Patients
    Kempf, Kerstin
    Roehling, Martin
    Niedermeier, Katja
    Gaertner, Babette
    Martin, Stephan
    NUTRIENTS, 2018, 10 (08):
  • [47] Insulin therapy for type 2 diabetes mellitus (vol 20, pg 245, 2007)
    Nisha, R. S.
    Bhatia, E.
    NATIONAL MEDICAL JOURNAL OF INDIA, 2007, 20 (06): : 310 - 310
  • [48] Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus (vol 50, pg 2611, 2007)
    Hiukka, A.
    Leinonen, E.
    Jauhiainen, M.
    Sundvall, J.
    Ehnholm, C.
    Keech, A. C.
    Taskinen, M. R.
    DIABETOLOGIA, 2007, 50 (12) : 2611 - 2613
  • [49] Usefulness of Insulin Degludec in Older Patients with Type 2 Diabetes Poorly Controlled by Previous Insulin Therapy
    Yoshida, Mami
    Oh, Eriko
    Kimata, Hiroe
    Yamamoto, Naomune
    Saeki, Akio
    Sugino, Masakazu
    Yoshida, Shigeru
    Kuzuya, Takeshi
    Ohsawa, Nakaaki
    Sano, Hiroyuki
    Hanafusa, Toshiaki
    DIABETES, 2016, 65 : A247 - A247
  • [50] Long-Term Safety, Tolerability and Efficacy of Ipragliflozin in Japanese Patients With Type 2 Diabetes Mellitus: IGNITE
    Kawano, Hiromichi
    Kashiwagi, Atsunori
    Kazuta, Kenichi
    Yoshida, Satoshi
    Ueyama, Eiji
    Utsuno, Atsushi
    DIABETES, 2012, 61 : A610 - A610
12345